Gene Editing Might Change What Being Human Actually Means
By Edd Gent,
Singularity Hub
| 04. 18. 2017
Attempts to distill the essence of “selfhood” have occupied philosophers for centuries. Consensus has been fleeting at best, but is likely to get even harder as genetic tools allow us to tweak our bodies and potentially our minds.
DNA-based technology’s entry into the mainstream has been picking up lately. Just last week, the FDA approved a genetic testing kit from Californian company 23andMe that lets customers find out how their genes could contribute to their chances of developing 10 diseases or passing them on to their children.
For the time being, this is where this technology is primarily directed—forewarning those whose DNA conspires against them. But rapid advances mean it is becoming increasingly feasible to go further and start editing out this defective code, either using gene therapies or editing genes in the embryo.
As the authors of an essay in Science last week noted, the imperative to help those afflicted by genetic disease could be causing us to ignore the significance of what it means to tinker with our genetic makeup.
“The urgency to rebuild ourselves following disease and...
Related Articles
By Staff [cites CGS' Katie Hasson], Radio New Zealand | 04.05.2025
At a time where some countries are struggling with low birth rates, the voices for pronatalism are getting louder. But it’s who’s sounding the call for more babies that has people talking.
Tech giant Elon Musk has fourteen children and...
By Amanda Hess, The New York Times | 04.05.2025
Image "Elon Musk" by Debbie Rowe on Wikimedia Commons licensed under CC by S.A. 3.0
For months, an internet-wide guessing game has swirled around the question of where Elon Musk’s intelligence falls on the bell curve. President Trump has called...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...